Skip to content

Lung Function and Inflammatory Markers in Cement Dust Exposed Workers: A Cross-shifts Study

Circulating Inflammatory Markers, Exhaled NO and Lung Function in Cement Production Workers; a Cross-shifts Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00727714
Acronym
LIS
Enrollment
95
Registered
2008-08-04
Start date
2008-04-30
Completion date
2009-01-31
Last updated
2016-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Obstruction

Keywords

Cement dust exposure, Cross-shift study, Lung function indices, Exhaled nitric oxide, Serum inflammatory markers

Brief summary

The aim of the study is to examine possible changes in lung function, nitric oxide levels and systemic inflammatory markers in cement dust exposed workers, during one shift (6-8 hours).

Detailed description

OBJECTIVE: Cement dust is suspected to be one of the main factors causing increased mortality among workers not only in the cement production industry, but also in the construction industry worldwide. Our aim is to examine possible changes in lung function, nitric oxide levels and systemic inflammatory markers in cement dust exposed workers, during one shift (6-8 hours). METHODS: All employees from Norwegian cement plants, are invited to participate. The workers will perform spirometry, single-breath determination of carbon monoxide uptake, blood samples before and after a working shift of 6-8 hours, and again after 24 hours. Information on respiratory symptoms, allergy and former respiratory disease as well as exposure information will be given on a self-reported questionnaire. Changes in lung function indices, nitric oxide levels and serum inflammatory markers will be calculated. Nitric oxide will only be measured in non-smokers. We will compare cement dust exposed workers with low-level or non-exposed workers (controls).

Interventions

None listed

Sponsors

Rikshospitalet University Hospital
CollaboratorOTHER
National Institute for Occupational Safety and Health (NIOSH/CDC)
CollaboratorFED
Sykehuset Telemark
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Employees from a Norwegian cement production plant

Exclusion criteria

* Exhaled nitric oxide measurements: smokers * Substantial previous work in quarry or as a miner

Design outcomes

Primary

MeasureTime frameDescription
Changes in Lung Function Measurements During One Work Shift (6-8h)baseline and 6-8hChanges in lung function measurements during one work shift (6-8h), spirometry and gass diffusion capacity

Secondary

MeasureTime frame
Changes in FeNO Measurements During One Shift (6-8h)baseline and 6-8h
Changes in Serum/Plasma Inflammatory Markers During One Shift (6-8h)Baseline and 6-8h
Changes in FeNO Measurements Between Baseline (0h) and 32 h0-32h
Changes in Serum/Plasma Inflammatory Markers Between Baseline and 32 h0-32h

Countries

Norway

Participant flow

Recruitment details

95 workers from two cement plants in Norway (located in the small cities of in Brevik in South-Norway and Kjøpsvik in the North-Norway) were examined in the winter sesons in 2008 and 2009.

Pre-assignment details

The workers were required to be off work for at least two days before Medical examinations, then exposed to cement Production dust between 0 and 8 h and again between 24 and 32 h. Those not exposed in these periods were excluded. No unexposed controls were included, the participants were their own controls.

Participants by arm

ArmCount
Exposed Workers
95 workers from two cement plants in Norway were included and examined pre and post shift (ohr and 8hr)and again after 24 hours.
95
Total95

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up2

Baseline characteristics

CharacteristicExposed Workers
Age, Continuous41 years
STANDARD_DEVIATION 13
BMI28 kg/m^2
STANDARD_DEVIATION 4
duration of exposure16 years
STANDARD_DEVIATION 13
Fraction of exhaled nitric oxide (FeNO)14 parts per billion
height179 cm
STANDARD_DEVIATION 7
Inflammatory markers in blood
IL-10
1.12 ng/litre
Inflammatory markers in blood
IL-1B
0.25 ng/litre
Region of Enrollment
Norway
95 participants
Sex: Female, Male
Female
7 Participants
Sex: Female, Male
Male
88 Participants
Smoking
Ex-smokers
22 participants
Smoking
Never-smokers
34 participants
Smoking
Smokers
39 participants
Spirometry
FEV1
3.92 Litres
STANDARD_DEVIATION 0.81
Spirometry
FVC
5.02 Litres
STANDARD_DEVIATION 0.91

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 95
serious
Total, serious adverse events
0 / 95

Outcome results

Primary

Changes in Lung Function Measurements During One Work Shift (6-8h)

Changes in lung function measurements during one work shift (6-8h), spirometry and gass diffusion capacity

Time frame: baseline and 6-8h

ArmMeasureGroupValue (MEAN)Dispersion
Exposed WorkersChanges in Lung Function Measurements During One Work Shift (6-8h)FVC4.99 LitresStandard Deviation 0.97
Exposed WorkersChanges in Lung Function Measurements During One Work Shift (6-8h)FEV13.88 LitresStandard Deviation 0.81
Secondary

Changes in FeNO Measurements Between Baseline (0h) and 32 h

Time frame: 0-32h

ArmMeasureValue (MEDIAN)
Exposed WorkersChanges in FeNO Measurements Between Baseline (0h) and 32 h12 ppb
Secondary

Changes in FeNO Measurements During One Shift (6-8h)

Time frame: baseline and 6-8h

Population: Problems With the FeNO (NIOX) device lead to few (58) included in FeNO measurements

ArmMeasureValue (MEDIAN)
Exposed WorkersChanges in FeNO Measurements During One Shift (6-8h)14 ppb
Secondary

Changes in Serum/Plasma Inflammatory Markers Between Baseline and 32 h

Time frame: 0-32h

ArmMeasureGroupValue (MEDIAN)
Exposed WorkersChanges in Serum/Plasma Inflammatory Markers Between Baseline and 32 hIL-100.97 ng/Litre
Exposed WorkersChanges in Serum/Plasma Inflammatory Markers Between Baseline and 32 hIL-1B0.20 ng/Litre
Secondary

Changes in Serum/Plasma Inflammatory Markers During One Shift (6-8h)

Time frame: Baseline and 6-8h

ArmMeasureGroupValue (MEDIAN)
Exposed WorkersChanges in Serum/Plasma Inflammatory Markers During One Shift (6-8h)IL-1B0.23 ng/Litre
Exposed WorkersChanges in Serum/Plasma Inflammatory Markers During One Shift (6-8h)IL-100.91 ng/Litre

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026